Ever Source Wealth Advisors, LLC Nuvalent, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 21 shares of NUVL stock, worth $1,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 22
4.55%
Holding current value
$1,768
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NUVL
# of Institutions
209Shares Held
59.5MCall Options Held
450KPut Options Held
619K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.68 Billion38.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5MShares$421 Million18.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$348 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$255 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.98MShares$251 Million7.96% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.62B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...